secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2026-06-10T21:19:17+00:00
Accession:  0001104659-26-072425
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fennec shareholders approve all proposals at 2026 annual meeting
----------------------------------------------------------------

- All five director nominees elected: Islam, Rallis, Brughera, Cook, Hackman with ~20M+ votes each.
- Haskell & White LLP ratified as auditor: 26,091,716 for, 134,491 withheld, 29,165 against.
- Advisory vote on executive compensation approved: 19,326,750 for, 336,060 against.
- Advisory frequency set to every year: 18,235,648 for one year, minimal votes for other intervals.
- Amendments to 2020 Equity Incentive Plan and adoption of 2026 Equity Inducement Plan approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/0001104659-26-072425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/tm2617550d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-072425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer